The World Health Organization has labeled antimicrobial resistance as a critical global public health issue.

MIT's Abdul Latif Jameel Clinic for Machine Learning in Health is employing artificial intelligence to find new antibiotics.

A new class of antibiotics has been discovered, with semapimod standing out for its effectiveness against certain resistant bacteria.

Semapimod is particularly potent against stationary-phase E. coli and A. baumannii and can breach the defenses of gram-negative bacteria.

Artificial intelligence has significantly hastened the process of identifying antibiotic properties, taking days instead of years.

This advancement is key to combating antibiotic-resistant bacteria and could save millions of lives.